NFE2L2 and breast carcinoma: This NRF2-NOTCH axis has been shown to affect cell proliferation in breast cancer cell lines (Zhang et al, 2019); NRF2 overexpression induced NOTCH signaling and cell proliferation whereas inhibition of NOTCH signaling by a γ-secretase inhibitor (DAPT) abrogated this phenotype.